Article

Star TribuneStar Tribune on 2022-03-29 22:52

Congressional subcommittee examines FDA handling of troubled Medtronic device

HeartWare was pulled from the market last year as growing clinical research suggested higher rate of stroke and death among patients with device.

Related news